Cell and gene therapies (CGTs) carry life-preserving and life-saving benefits, profoundly affecting patients and their families. While the successes and growth are extraordinary, they are also costly, often administered in single doses costing between $300,000 and $3.5 million per treatment.

Gain insights into how best to determine population and pipeline risk; explore coverage options; understand non-traditional payment options; learn about new care delivery approaches; and offer targeted employee communications and education.